Antisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3
Open Access
- 3 June 2010
- journal article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 29 (1) , 63
Abstract
Background and Aim: in recent years, Livin, a new member of IAPs family, is found to be a key molecule in cancers. Researchers consider Livin may become a new target for tumor therapy; however, the role of it in bladder cancer is still unclear. The purpose of this article is to investigate Antisense Oligonucleotide (ASODN) of Livin on treating bladder cancer cell and underlying mechanisms.Methods: Phosphorathioate modifying was used to synthesize antisense oligonucleotides targeting Livin, followed by transfection into human bladder cancer cell 5637. After transfection, Livin mRNA and protein level, cell proliferation and apoptosis changes, caspase3 level and its effect on human bladder cancer transplantable tumor in nude mice were measured.Result: results showed Livin ASODN effectively inhibited Livin expression and tumor cell proliferation, and these effects probably through enhanced caspase3 activity and apoptosis of tumor cells. In nude mice transplantable tumor model, Livin expressions were inhibited meanwhile caspase3 expression was increased. Tumor growth slowed down and apoptosis was enhanced.Conclusion: Our data suggest that Livin plays an important role in inhibiting apoptosis of bladder cancer cells. Livin ASODN may promote cell apoptosis, inhibit bladder cancer growth, and become one of the methods of gene therapy for bladder cancer.Keywords
This publication has 21 references indexed in Scilit:
- Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinomaBMC Cancer, 2009
- Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancyMolecular Cancer Therapeutics, 2007
- Expression of the Apoptosis Inhibitor Livin in Renal Cell Carcinomas: Correlations with Pathology and OutcomeTumor Biology, 2007
- Lack of Pharmacokinetic Interaction for ISIS 113715, a 2???-0-Methoxyethyl Modified Antisense Oligonucleotide Targeting Protein Tyrosine Phosphatase 1B Messenger RNA, with Oral Antidiabetic Compounds Metformin, Glipizide or RosiglitazoneClinical Pharmacokinetics, 2006
- A Phase I Pharmacokinetic and Pharmacodynamic Study of OGX-011, a 2′-Methoxyethyl Antisense Oligonucleotide to Clusterin, in Patients With Localized Prostate CancerJNCI: Journal of the National Cancer Institute, 2005
- IAP proteins: blocking the road to death's doorNature Reviews Molecular Cell Biology, 2002
- Livin, a Novel Inhibitor of Apoptosis Protein Family MemberJournal of Biological Chemistry, 2001
- A Human IAP-Family Gene, Apollon, Expressed in Human Brain Cancer CellsBiochemical and Biophysical Research Communications, 1999
- Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genesNature, 1996
- The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteinsCell, 1995